Loading chat...
GA HR1717
Resolution
Status
Passed
3/5/2012
Primary Sponsor
Sharon Cooper
Click for details
AI Summary
- Commends ViaCyte, a stem cell engineering company dedicated to creating and commercializing therapies to treat diabetes, for its contributions to patients with diabetes and dedication toward finding a cure
- Recognizes ViaCyte's development of a device that attaches stem cell-derived pancreatic cells to a plastic mesh for implantation into diabetic patients to control blood sugar
- Notes the company has tested its device in more than 3,000 animals, consistently finding that blood sugar is controlled with the device, and believes it is close to human trials
- Highlights that approximately 3 million people are diagnosed with Type 1 diabetes in America, accumulating millions of dollars in medicine and treatment costs over their lifetimes
- Directs the Clerk of the House of Representatives to transmit a copy of the resolution to ViaCyte
Legislative Description
ViaCyte; commend
Last Action
House Read and Adopted
3/5/2012
Full Bill Text
No bill text available